Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

4.38
-0.1350-2.99%
Post-market: 4.380.00000.00%16:10 EDT
Volume:44.09K
Turnover:197.92K
Market Cap:75.24M
PE:-2.52
High:4.84
Open:4.56
Low:4.37
Close:4.52
52wk High:9.82
52wk Low:3.28
Shares:17.18M
Float Shares:6.78M
Volume Ratio:1.02
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7400
EPS(LYR):-1.6791
ROE:-240.35%
ROA:-43.98%
PB:17.47
PE(LYR):-2.61

Loading ...

Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 13

Verrica Pharmaceuticals Q1 Adjusted EPS USD -0.41

THOMSON REUTERS
·
May 13

Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 09

BRIEF-Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data

Reuters
·
May 06

Verrica presents Phase 2 data showing VP-315 shrinks untreated basal cell tumors 67%

Reuters
·
May 06

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of Vp-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (Sid) Annual Meeting

THOMSON REUTERS
·
May 06

Verrica Pharmaceuticals sets conference call for first-quarter 2026 results update

Reuters
·
May 05

Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026

THOMSON REUTERS
·
May 05

Verrica Pharmaceuticals announces annual shareholder meeting at company headquarters

Reuters
·
Apr 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Johnson & Johnson (JNJ)

TIPRANKS
·
Apr 16

Verrica late-breaking Phase 2 VP-315 data suggests abscopal effect in basal cell carcinoma

Reuters
·
Apr 10

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of Vp-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

THOMSON REUTERS
·
Apr 10

Verrica Pharma CEO to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 06